TCS HDAC6 20b

CAS: 956154-63-5

Ref. 3D-GNB15463

Produktinformation

• Name: TCS HDAC6 20b

Beschreibung

TCS HDAC6 20b is a histone deacetylase (HDAC) inhibitor that is used in the treatment of chronic obstructive pulmonary disease. TCS HDAC6 20b inhibits HDAC activity and acetylation of histones, leading to changes in chromatin structure and gene expression. It is also used for the treatment of silicosis, collagen diseases, and cancer. TCS HDAC6 20b has been shown to increase the production of growth factors such as erythropoietin in mammalian cells. This drug also reduces DNA methylation by inhibiting the enzyme DNA methyltransferase.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 480.7 g/mol
• Formel: C₂₆H₄₄N₂O₄S
• Reinheit: Min. 95%